Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 13, 2020

SELL
$3.99 - $5.46 $211,470 - $289,380
-53,000 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$4.34 - $5.86 $113,708 - $153,532
-26,200 Reduced 33.08%
53,000 $253,000
Q3 2019

Nov 08, 2019

SELL
$4.93 - $5.8 $161,704 - $190,240
-32,800 Reduced 29.29%
79,200 $406,000
Q2 2019

Aug 09, 2019

BUY
$5.22 - $6.1 $584,640 - $683,200
112,000 New
112,000 $636,000

Others Institutions Holding SIGA

About SIGA TECHNOLOGIES INC


  • Ticker SIGA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 73,024,096
  • Market Cap $434M
  • Description
  • SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...
More about SIGA
Track This Portfolio

Track Skandinaviska Enskilda Banken Ab (Publ) Portfolio

Follow Skandinaviska Enskilda Banken Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.